Immunoglobulin G1, Anti-(Human Tissue Factor Pathway Inhibitor) (Human Monoclonal Pf-06741086 .Gamma.1-Chain), Disulfide With Human Monoclonal Pf-06741086 .Lambda.-Chain, Dimer
Hemophilia
Institute of Hematology & Blood Diseases Hospital, Chinamonoclonal_antibodyPhase 2Active
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
16 Active assets in the Hemophilia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT Chulalongkorn University | Phase 4 | BB |
Stsp-0601 For Jiangsu BioJeTay Biotechnology Co., Ltd. | Phase 3 | BB |
Factor Viii Inhibitor Bypassing Fraction Baxalta now part of Shire | Phase 3 | BB |
Ribavirin Kenneth Sherman | Phase 4 | BB |
PEGYINTERFERON-ALFA-2A Baqiyatallah Medical Sciences University | Phase 4 | BB |
View all 32 →
Same molecule, other indications
Immunoglobulin G1, Anti-(Human Tissue Factor Pathway Inhibitor) (Human Monoclonal Pf-06741086 .Gamma.1-Chain), Disulfide With Human Monoclonal Pf-06741086 .Lambda.-Chain, Dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →